IHEvsJDOC
iShares U.S. Pharmaceuticals ETF against JPMorgan Healthcare Leaders ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| IHE | JDOC | |
|---|---|---|
| Expense ratio | 0.37% | 0.65% |
| Assets | $1.7B | $10M |
| Net flow, 1 month | +$49M | — |
| Net flow, 1 year | +$722M | −$27K |
| Return, YTD | +29.2% | +15.7% |
| Return, 1 year | — | — |
| Avg daily volume | 270K | 1K |
| Holdings | 52 | 54 |
| Listed | May 1, 2006 | Oct 31, 2023 |
| Options market | Yes | No |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS